Cara Therapeutics | CARA - Capitale Ordinario





Capitale Ordinario Cambiamento Data
Acadia Pharmaceuticals USD 169.18M 470K 2025-12
Alterity Therapeutics Limited AUD 10.88B 10.66B 2025-12
Assertio Holdings USD 9K 0 2023-12
Cara Therapeutics USD 9.38M 9.38M 2025-09
Cassava Sciences USD 48.31M 0 2025-12
Chugai Pharma JPY 1.65B 50K 2026-03
Cipla INR 807.78M 17K 2026-03
Clal Biotechnology ILS 1.61M 0 2022-12
Compugen USD 94.55M 1.02M 2025-12
CSL USD 482.13M 93.87M 2025-12
Grifols EUR 680.58M 846.11K 2025-12
Halozyme Therapeutics USD 118.52M 741K 2026-03
J&J USD 2.41B 1.74M 2025-12
Neurocrine Biosciences USD 100.6M 500K 2026-03
Pacira USD 39.31M 1.81M 2026-03
Pfizer USD 5.7B 13M 2026-03
RedHill Biopharma USD 50.92B 17.62B 2025-12
Supernus Pharmaceuticals USD 58.04M 582K 2026-03
Vanda Pharmaceuticals USD 58K 0 2024-12